Bothell, WA, United States of America

Yufeng Peng

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Qilu Puget Sound Biotherapeutics Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yufeng Peng. Retrieved from https://idiyas.com/inventor/yufeng-peng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yufeng Peng: Innovator in Biotherapeutics

Introduction

Yufeng Peng is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biotherapeutics, particularly through his innovative work on antibodies.

Latest Patents

Yufeng Peng holds a patent for "Anti-CCR8 Antibodies." This patent represents a crucial advancement in therapeutic options for various diseases, showcasing his expertise and dedication to improving healthcare.

Career Highlights

Yufeng Peng is currently employed at Qilu Puget Sound Biotherapeutics Corporation. His role at the company allows him to leverage his skills and knowledge in the development of groundbreaking biotherapeutic solutions.

Collaborations

Yufeng collaborates with Jamil Haque, a fellow innovator in the field. Their partnership exemplifies the importance of teamwork in driving forward scientific advancements.

Conclusion

Yufeng Peng's contributions to biotherapeutics through his patent and work at Qilu Puget Sound Biotherapeutics Corporation highlight his role as a key innovator in the industry. His efforts continue to pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…